: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

Valvular Heart Disease

Free Subscription

Articles published in Int J Cardiol
Retrieve available abstracts of 381 articles:
HTML format

Single Articles

July 2024

TIRADO-CONTE G, Pardo Sanz A, Salido Tahoces L
Ascending aortic dilatation in TAVI: Actor or bystander?
Int J Cardiol. 2024;406:132089.
PubMed

June 2024

RUSSO G, Hahn RT, Alessandrini H, Andreas M, et al
Effects of tricuspid transcatheter edge-to-edge repair on tricuspid annulus diameter - Data from the TriValve registry.
Int J Cardiol. 2024;405:131934.
PubMed Abstract available

PARATZ ED, Stub D, Sutherland N, Gutman S, et al
Response to: Regard to assessing agreement between two raters with kappa statistics.
Int J Cardiol. 2024;404:131978.
PubMed

GESKE JB, Schaff HV
Role of experience in myectomy for hypertrophic cardiomyopathy: With very high procedural volume, myectomy remains low-risk even with concomitant procedure need.
Int J Cardiol. 2024;404:131961.
PubMed

ANG SP, Chia JE
Reevaluating female survival benefit in TAVR: A closer look in the current era.
Int J Cardiol. 2024;404:131935.
PubMed

May 2024

MONDA E, Boccia A, Altobelli I, Mauriello A, et al
Effect of beta-blockers and angiotensin receptor blockers in reducing the aortic growth rate in children with bicuspid aortic valve-related aortopathy.
Int J Cardiol. 2024;408:132067.
PubMed Abstract available

VOGES I, Hansen JH
Critical aortic stenosis - The long-term burden.
Int J Cardiol. 2024;408:132134.
PubMed

ALPERI A, Pascual I, Moris C, Avanzas P, et al
Neo 2 transcatheter heart valve system: Direct towards a minimalistic procedure.
Int J Cardiol. 2024;402:131883.
PubMed

VESELKA J
Estimating the risk of sudden death in hypertrophic cardiomyopathy might be solved by artificial intelligence.
Int J Cardiol. 2024;402:131842.
PubMed

GARAGOLI F, Chiabrando JG, Seropian IM, Lombardi M, et al
Stroke risk after transcatheter aortic valve replacement in patients with carotid stenosis: A systematic review and meta-analysis.
Int J Cardiol. 2024 May 1:132085. doi: 10.1016/j.ijcard.2024.132085.
PubMed Abstract available

April 2024

QIU Y, Li M, Song X, Li Z, et al
Predictive nomogram for 28-day mortality risk in mitral valve disorder patients in the intensive care unit: A comprehensive assessment from the MIMIC-III database.
Int J Cardiol. 2024 Apr 25:132105. doi: 10.1016/j.ijcard.2024.132105.
PubMed Abstract available

LEE CY, Tsai CM, Chiang KC, Huang CC, et al
Prognostic value of left ventricular and left atrial strain imaging in moderate to severe aortic stenosis: Insights from an Asian population.
Int J Cardiol. 2024 Apr 25:132103. doi: 10.1016/j.ijcard.2024.132103.
PubMed Abstract available

CHEN B, Zhang Q
The role of left ventricular global work index on the prediction of cardiovascular mortality after transcatheter aortic valve implantation.
Int J Cardiol. 2024 Apr 23:132101. doi: 10.1016/j.ijcard.2024.132101.
PubMed

MARMAGKIOLIS K, Monlezun DJ, Caballero J, Cilingiroglu M, et al
Prevalence, mortality, cost, and disparities in transcatheter mitral valve repair and replacement in cancer patients: Artificial intelligence and propensity score national 5-year analysis of 7495 procedures.
Int J Cardiol. 2024 Apr 23:132091. doi: 10.1016/j.ijcard.2024.132091.
PubMed Abstract available

GUO Y, Li H, Huang B, Hou L, et al
LncRNA HOTAIR ameliorates calcific aortic valve disease by sponging miR-29b.
Int J Cardiol. 2024 Apr 23:132094. doi: 10.1016/j.ijcard.2024.132094.
PubMed

GERHARDT P, Shehu N, Ferrari I, Hullebrandt M, et al
Quantifying aortic valve regurgitation in patients with congenital aortic valve disease by 2D and 4D flow magnetic resonance analysis.
Int J Cardiol. 2024 Apr 21:132084. doi: 10.1016/j.ijcard.2024.132084.
PubMed Abstract available

DAHME T
Effects of tricuspid edge-to-edge repair beyond leaflet approximation: Evidence for indirect tricuspid annuloplasty.
Int J Cardiol. 2024;406:132066.
PubMed

SADEGHIPOUR P, Mozafarybazargany M, Farrashi M, De Caterina R, et al
Response to "Characteristics of the prothrombotic milieu in mitral stenosis patients managed with direct oral anticoagulants".
Int J Cardiol. 2024 Apr 20:132076. doi: 10.1016/j.ijcard.2024.132076.
PubMed

PRAKASH SK
Editorial on Bellino et al., "Aortopathy and aortic valve surgery in patients with bicuspid aortic valve with and without raphe".
Int J Cardiol. 2024 Apr 16:132047. doi: 10.1016/j.ijcard.2024.132047.
PubMed

CHENG Y, Zhang Q
Commentary on the mitral regurgitation outcomes after transcatheter atrial septal defect closure.
Int J Cardiol. 2024 Apr 6:132033. doi: 10.1016/j.ijcard.2024.132033.
PubMed

ALTIBI AM, Sapru A, Ghanem F, Zhao Y, et al
Impact of concomitant surgical interventions on outcomes of septal myectomy in obstructive hypertrophic cardiomyopathy.
Int J Cardiol. 2024;400:131790.
PubMed Abstract available

DE SA MARCHI MF, van den Dorpel M, Calomeni P, Chatterjee S, et al
Comparative analysis of different risk prediction tools after mitral Transcatheter edge-to-edge repair.
Int J Cardiol. 2024;400:131768.
PubMed Abstract available

March 2024

SANG SLW, Weissman C, Parker J, Timek T, et al
Contemporary outcomes of surgical aortic valve replacement in patients referred for a transcatheter approach.
Int J Cardiol. 2024 Mar 30:132004. doi: 10.1016/j.ijcard.2024.132004.
PubMed Abstract available

BELLINO M, Antonini-Canterin F, Bossone E, Faggiano P, et al
Aortopathy and aortic valve surgery in patients with bicuspid aortic valve with and without raphe.
Int J Cardiol. 2024 Mar 30:132000. doi: 10.1016/j.ijcard.2024.132000.
PubMed Abstract available

BLEIZIFFER S, Appleby C, Delgado V, Eltchaninoff H, et al
Patterns of aortic valve replacement in Europe and adoption by sex.
Int J Cardiol. 2024 Mar 28:131996. doi: 10.1016/j.ijcard.2024.131996.
PubMed Abstract available

KALKAN S, Gursoy MO, Guner A, Kalcik M, et al
Management of prosthetic valve thrombosis with unfractionated heparin.
Int J Cardiol. 2024 Mar 19:131968. doi: 10.1016/j.ijcard.2024.131968.
PubMed Abstract available

BICHUETTE LD, Lottenberg MP, Caramelli B
Hypertrophic cardiomyopathy as a high-risk feature on perioperative care: How to deal with this self-fulfilling prophecy?
Int J Cardiol. 2024;399:131683.
PubMed

ZACH DK, Schwegel N, Santner V, Winkelbauer L, et al
Low-grade systemic inflammation and left ventricular dysfunction in hypertensive compared to non-hypertensive hypertrophic cardiomyopathy.
Int J Cardiol. 2024;399:131661.
PubMed Abstract available

NASCIMENTO BR, Nunes MCP, da Silva JLP, Steer A, et al
Outcomes of latent rheumatic heart disease: External validation of a simplified score in patients with and without secondary prophylaxis.
Int J Cardiol. 2024;399:131662.
PubMed Abstract available

FENG D, Zhao J, Niu G, Zhang Y, et al
Outcomes for patients undergoing transcatheter aortic valve replacement with ascending aorta dilation.
Int J Cardiol. 2024 Mar 11:131948. doi: 10.1016/j.ijcard.2024.131948.
PubMed Abstract available

BONELLO B, Issitt R, Hughes M, Carr M, et al
Long-term outcome after neonatal intervention for congenital critical aortic stenosis.
Int J Cardiol. 2024 Mar 2:131932. doi: 10.1016/j.ijcard.2024.131932.
PubMed Abstract available

BARSSOUM K, Abumoawad A, Chowdhury M, Agrawal A, et al
Perioperative outcomes of hypertrophic cardiomyopathy: An insight from the National Readmission Database.
Int J Cardiol. 2024;398:131601.
PubMed Abstract available

LIU Z, Wei P, Jiang H, Zhang F, et al
Corrigendum to 'Alerting trends in epidemiology for non-rheumatic degenerative mitral valve disease, 1990-2019: An age-period-cohort analysis for the Global Burden of Disease Study 2019' [Int. J. Cardiol. 395(2024) 131561].
Int J Cardiol. 2024 Mar 1:131919. doi: 10.1016/j.ijcard.2024.131919.
PubMed

February 2024

BOURG C, Lee KC, Donal E
Understanding myocardial mechanics in primary mitral regurgitation: A contemporary approach.
Int J Cardiol. 2024 Feb 17:131882. doi: 10.1016/j.ijcard.2024.131882.
PubMed

DI MAURO M, Guarracini S, Mazzocchetti L, Capuzzi D, et al
Transcatheter bicaval valve system for the treatment of severe isolated tricuspid regurgitation. Features from a single-Centre experience.
Int J Cardiol. 2024 Feb 16:131864. doi: 10.1016/j.ijcard.2024.131864.
PubMed Abstract available

AKHTAR KH, Pahuja M, Baber U
Self-expanding or balloon-expandable valve for TAVR in low risk patients: The jury is still out!
Int J Cardiol. 2024;397:131619.
PubMed

DE MARZO V, Zimarino M
The value of transaxillary access for TAVI.
Int J Cardiol. 2024;397:131448.
PubMed

FATIMA K, Uddin QS, Tharwani ZH, Kashif MAB, et al
Concomitant transthyretin cardiac amyloidosis in patients undergoing TAVR for aortic stenosis: A systemic review and meta-analysis.
Int J Cardiol. 2024 Feb 15:131854. doi: 10.1016/j.ijcard.2024.131854.
PubMed Abstract available

DANDEL M
It is time to think about further optimization of the echocardiographic assessment of left ventricular responses to mitral regurgitation.
Int J Cardiol. 2024 Feb 9:131841. doi: 10.1016/j.ijcard.2024.131841.
PubMed

KWAK S, Lee HJ, Lee H, Park JB, et al
Age-dependent association of metabolic dyslipidemia with clinical expression of hypertrophic cardiomyopathy.
Int J Cardiol. 2024;396:131574.
PubMed Abstract available

January 2024

KURASAWA S, Imaizumi T, Kondo T, Hishida M, et al
Relationship between peak aortic jet velocity and progression of aortic stenosis in patients undergoing hemodialysis.
Int J Cardiol. 2024 Jan 30:131822. doi: 10.1016/j.ijcard.2024.131822.
PubMed Abstract available

ELKOUMY A, Ruck A, Abdel-Wahab M, Thiele H, et al
ACURATE neo2 Transcatheter aortic valve implantation without balloon aortic valvuloplasty - direct ACURATE neo2.
Int J Cardiol. 2024 Jan 19:131792. doi: 10.1016/j.ijcard.2024.131792.
PubMed Abstract available

MUSUMECI B, Tini G, Biagini E, Merlo M, et al
Clinical characteristics and outcome of end stage hypertrophic cardiomyopathy: Role of age and heart failure phenotypes.
Int J Cardiol. 2024 Jan 18:131784. doi: 10.1016/j.ijcard.2024.131784.
PubMed Abstract available

CARABETTA N, Siller-Matula JM, Boccuto F, Panuccio G, et al
Commissural alignment during TAVR reduces the risk of overlap to coronary ostia.
Int J Cardiol. 2024;395:131572.
PubMed Abstract available

PARATZ ED, Stub D, Sutherland N, Gutman S, et al
The challenge of risk stratification in hypertrophic cardiomyopathy: Clinical, genetic and imaging insights from a quaternary referral centre.
Int J Cardiol. 2024;395:131416.
PubMed Abstract available

DEL FRANCO A, Biagioni G, Mazzoni C, Cappelli F, et al
Amyloidosis in spinal stenosis: How, when and whether cardiac screening has a clinical impact.
Int J Cardiol. 2024;395:131413.
PubMed

SRAYA R, Amsalem I, Carasso S, Gilad O, et al
Mitral valve gradient changes associate with outcomes of patients undergoing transcatheter edge-to-edge repair.
Int J Cardiol. 2024 Jan 9:131766. doi: 10.1016/j.ijcard.2024.131766.
PubMed Abstract available

PASTORE MC, Vannuccini F, Mandoli GE, Lisi M, et al
Myocardial work and left heart deformation parameters across primary mitral regurgitation severity.
Int J Cardiol. 2024 Jan 9:131772. doi: 10.1016/j.ijcard.2024.131772.
PubMed Abstract available

LERMAN TT, Levi A, Kornowski R
Response to: "Evolut R and Evolut PRO vs. Sapien 3 for transcatheter aortic valve implantation - The 'generation gap' and beyond".
Int J Cardiol. 2024 Jan 5:131751. doi: 10.1016/j.ijcard.2024.131751.
PubMed

VAN WELY M, van Nieuwkerk AC, Rooijakkers M, van der Wulp K, et al
Transaxillary versus transfemoral access as default access in TAVI: A propensity matched analysis.
Int J Cardiol. 2024;394:131353.
PubMed Abstract available

December 2023

MOSCARELLA E, Ielasi A, Montonati C, Pellegrini D, et al
Comparing two-year outcomes of balloon-expandable Myval and self-expanding Evolut R in severe aortic valve stenosis.
Int J Cardiol. 2023 Dec 31:131701. doi: 10.1016/j.ijcard.2023.131701.
PubMed Abstract available

ANWER S, Nussbaum S, Winkler NE, Benz DC, et al
Left ventricular global work index and prediction of cardiovascular mortality after transcatheter aortic valve implantation.
Int J Cardiol. 2023 Dec 29:131660. doi: 10.1016/j.ijcard.2023.131660.
PubMed Abstract available

HIRAM R
The duration of atrial fibrillation might be associated with right heart disease severity.
Int J Cardiol. 2023 Dec 28:131689. doi: 10.1016/j.ijcard.2023.131689.
PubMed

ANTIA A, Pius R, Ndukauba C, Zarauz VR, et al
Temporal trends in the utilization and outcome of transcatheter aortic valve replacement across racial and ethnic groups. A nationwide analysis.
Int J Cardiol. 2023 Dec 22:131669. doi: 10.1016/j.ijcard.2023.131669.
PubMed Abstract available

CAETANO L DA SILVA, Gibicoski TB, Rodriguez F, Scabello I, et al
Impact of carotid artery stenosis on outcomes of transcatheter aortic valve replacement: A systematic review and meta-analysis.
Int J Cardiol. 2023 Dec 22:131670. doi: 10.1016/j.ijcard.2023.131670.
PubMed Abstract available

ADAMO M, Pagnesi M, Di Pasquale M, Ravera A, et al
Differential biomarker expression in heart failure patients with and without mitral regurgitation: Insights from BIOSTAT-CHF.
Int J Cardiol. 2023 Dec 21:131664. doi: 10.1016/j.ijcard.2023.131664.
PubMed Abstract available

IZUMI K, Utsunomiya H, Takeuchi M, Hamada A, et al
Relationship between duration of atrial fibrillation and right heart structure remodeling as assessed by 3-dimensional transesophageal echocardiography.
Int J Cardiol. 2023 Dec 21:131667. doi: 10.1016/j.ijcard.2023.131667.
PubMed Abstract available

BOLETI OD, Roussos S, Norrish G, Field E, et al
Sudden cardiac death in childhood RASopathy-associated hypertrophic cardiomyopathy: Validation of the HCM risk-kids model and predictors of events.
Int J Cardiol. 2023;393:131405.
PubMed Abstract available

OZLEK B
Tricuspid regurgitation and heart failure with preserved ejection fraction: An enigma in cardiology practice.
Int J Cardiol. 2023 Dec 10:131649. doi: 10.1016/j.ijcard.2023.131649.
PubMed

GOZDEK M, Kowalewski M
Evolut R and Evolut PRO vs. Sapien 3 for transcatheter aortic valve implantation - The 'generation gap' and beyond.
Int J Cardiol. 2023 Dec 8:131647. doi: 10.1016/j.ijcard.2023.131647.
PubMed

SEE C, Wang Y, Yang Y, Tirziu D, et al
Impact of sex on transcatheter aortic valve replacement outcomes: Results of a single-center study.
Int J Cardiol. 2023 Dec 6:131643. doi: 10.1016/j.ijcard.2023.131643.
PubMed Abstract available

HOLIEROOK M, Henstra MJ, Dolman DJ, Chekanova EV, et al
Higher Edmonton Frail Scale prior to transcatheter Aortic Valve Implantation is related to longer hospital stay and mortality.
Int J Cardiol. 2023 Dec 6:131637. doi: 10.1016/j.ijcard.2023.131637.
PubMed Abstract available

MATTIG I, Steudel T, Barzen G, Frumkin D, et al
Diagnostic value of papillary muscle hypertrophy and mitral valve thickness to discriminate cardiac amyloidosis and Fabry disease.
Int J Cardiol. 2023 Dec 3:131629. doi: 10.1016/j.ijcard.2023.131629.
PubMed Abstract available

November 2023

FERNANDEZ-GOLFIN C, Gonznalez-Gomez A
Unmasking tricuspid regurgitation.
Int J Cardiol. 2023 Nov 28:131609. doi: 10.1016/j.ijcard.2023.131609.
PubMed

KIKUCHI S, Minamimoto Y, Matsushita K, Cho T, et al
Ratio of left ventricular outflow tract area to aortic annulus area and complete atrioventricular block after transcatheter aortic valve replacement for aortic stenosis.
Int J Cardiol. 2023 Nov 27:131608. doi: 10.1016/j.ijcard.2023.131608.
PubMed Abstract available

CHAN J, Narayan P, Fudulu DP, Dong T, et al
Trend in mitral valve prostheses of choice and early outcomes in the United Kingdom.
Int J Cardiol. 2023 Nov 25:131607. doi: 10.1016/j.ijcard.2023.131607.
PubMed Abstract available

HAUGE SW, Estensen ME, Persson R, Abebe S, et al
The importance of concomitant mitral regurgitation for estimates of mitral valve area by pressure half time in patients with chronic rheumatic heart disease.
Int J Cardiol. 2023 Nov 21:131600. doi: 10.1016/j.ijcard.2023.131600.
PubMed Abstract available

MOSCARELLI M, Sollami G, Lentini E, Prestera R, et al
About different localization of hypoattenuated lesions following transcatheter aortic valve replacement.
Int J Cardiol. 2023 Nov 16:131597. doi: 10.1016/j.ijcard.2023.131597.
PubMed Abstract available

HU D, Lan T, Chen Y, Chen L, et al
An 18-year evolution of congenital heart disease in China: An echocardiographic database-based study.
Int J Cardiol. 2023;391:131286.
PubMed Abstract available

KHOURY S, Bhatia RT, Marwaha S, Miles C, et al
Ethnic and sex-related differences at presentation in apical hypertrophic cardiomyopathy: An observational cross-sectional study.
Int J Cardiol. 2023;391:131265.
PubMed Abstract available

WU Z, Nie C, Zhu C, Meng Y, et al
Mitral annular calcification in obstructive hypertrophic cardiomyopathy: Incidence, risk factors, and prognostic value after myectomy.
Int J Cardiol. 2023;391:131266.
PubMed Abstract available

DE SARRO R, Sabatino J
Left atrial function's evaluation in aortic stenosis: A clinical imperative.
Int J Cardiol. 2023 Nov 11:131579. doi: 10.1016/j.ijcard.2023.131579.
PubMed

LOSI MA, Monda E, Lombardi R, Lioncino M, et al
Prediction of incident atrial fibrillation in hypertrophic cardiomyopathy.
Int J Cardiol. 2023 Nov 9:131575. doi: 10.1016/j.ijcard.2023.131575.
PubMed Abstract available

ZHOU N, Liu A, Weng H, Liu W, et al
Three-dimensional echocardiography reveals early mitral valve alterations in hypertrophic cardiomyopathy genetic mutation carriers.
Int J Cardiol. 2023 Nov 8:131576. doi: 10.1016/j.ijcard.2023.131576.
PubMed Abstract available

DORES H, Toste A, Cardim N
Hypertrophic cardiomyopathy in patients with a normal electrocardiogram: A view from the east side of the Atlantic Ocean.
Int J Cardiol. 2023;390:131260.
PubMed Abstract available

SALA A, Alfieri O
Surgical ablation in hypertrophic obstructive cardiomyopathy: What is the real deal?
Int J Cardiol. 2023;390:131146.
PubMed

NEMES A
Three-dimensional echocardiography for Tricuspid Annulus - Transthoracic or transoesophageal approach?
Int J Cardiol. 2023;390:131170.
PubMed

October 2023

BRANDES A
Rheumatic mitral valve stenosis and atrial fibrillation - Vicious twins.
Int J Cardiol. 2023 Oct 30:131566. doi: 10.1016/j.ijcard.2023.131566.
PubMed

LIU Z, Wei P, Jiang H, Zhang F, et al
Alerting trends in epidemiology for non-rheumatic degenerative mitral valve disease, 1990-2019: An age-period-cohort analysis for the Global Burden of Disease Study 2019.
Int J Cardiol. 2023 Oct 30:131561. doi: 10.1016/j.ijcard.2023.131561.
PubMed Abstract available

MOSCARELLI M, Prestera R, Fiore C, Pernice V, et al
Evaluation of the anatomic sinus after transcatheter aortic valve replacement.
Int J Cardiol. 2023 Oct 20:131551. doi: 10.1016/j.ijcard.2023.131551.
PubMed Abstract available

HOU Q, Wu W, Fang L, Zhang X, et al
Patient-specific computational fluid dynamics for hypertrophic obstructive cardiomyopathy.
Int J Cardiol. 2023;389:131263.
PubMed Abstract available

BADWAN O, Mirzai S, Skoza W, Hawk F, et al
Clinical outcomes following tricuspid transcatheter edge-to-edge repair with PASCAL: A meta-analysis.
Int J Cardiol. 2023;389:131194.
PubMed Abstract available

LEONARDI D, Bursi F, Fanti D, Dotto A, et al
Outpatient tricuspid regurgitation in the community: Clinical context and outcome.
Int J Cardiol. 2023 Oct 14:131443. doi: 10.1016/j.ijcard.2023.131443.
PubMed Abstract available

BHOGAL S, Waksman R, Shea C, Zhang C, et al
Self-expanding and balloon-expandable valves in low risk TAVR patients.
Int J Cardiol. 2023 Oct 12:131431. doi: 10.1016/j.ijcard.2023.131431.
PubMed Abstract available

MYAGMARDORJ R, Stassen J, Nabeta T, Hirasawa K, et al
Impact of chronic obstructive pulmonary disease on right ventricular function and remodeling after aortic valve replacement.
Int J Cardiol. 2023 Oct 5:131414. doi: 10.1016/j.ijcard.2023.131414.
PubMed Abstract available

CHEN X
The real world of stroke incidence in patients with hypertrophic cardiomyopathy.
Int J Cardiol. 2023;388:131172.
PubMed

MARTIN M, Moris C
Subclinical leaflet thrombosis after TAVI: To be or not to be.
Int J Cardiol. 2023;388:131140.
PubMed

September 2023

YAMANO M, Yamano T, Nakamura T, Zukeran T, et al
Mitral regurgitation outcomes after transcatheter atrial septal defect closure.
Int J Cardiol. 2023 Sep 28:131404. doi: 10.1016/j.ijcard.2023.131404.
PubMed Abstract available

WINKLER NE, Anwer S, Rumpf PM, Tsiourantani G, et al
Left atrial pump strain predicts long-term survival after transcatheter aortic valve implantation.
Int J Cardiol. 2023 Sep 28:131403. doi: 10.1016/j.ijcard.2023.131403.
PubMed Abstract available

CHANG WT, Lin CH, Lee WC, Kan WC, et al
Signal intensity coefficient as a detector of aortic stenosis-induced myocardial fibrosis and its correlation to the long term outcome.
Int J Cardiol. 2023 Sep 17:131367. doi: 10.1016/j.ijcard.2023.131367.
PubMed Abstract available

KHARBANDA RK, Ramdat Misier NL, Van den Eynde J, El Mathari S, et al
Outcomes of concomitant surgical ablation in patients undergoing surgical myectomy for hypertrophic obstructive cardiomyopathy: A systematic review and meta-analysis.
Int J Cardiol. 2023;387:131099.
PubMed Abstract available

SOARES JR, Carvalho VT, Lodi-Junqueira L, Fonseca IMG, et al
Assessment of the left atrial volume and function following percutaneous mitral balloon valvuloplasty: Insights into acute and late impact of atrial fibrillation on atrial remodeling.
Int J Cardiol. 2023 Sep 12:131361. doi: 10.1016/j.ijcard.2023.131361.
PubMed Abstract available

LEOW R, Kong WKF, Li TY, Poh KK, et al
Yeo's index: A novel index that combines anatomic and haemodynamic assessment of the severity of mitral stenosis.
Int J Cardiol. 2023 Sep 7:131350. doi: 10.1016/j.ijcard.2023.131350.
PubMed Abstract available

HASEGAWA H, Kuwajima K, Kagawa S, Yamane T, et al
Impact of eccentric jet on outcomes in patients with atrial functional mitral regurgitation: An echocardiographic study.
Int J Cardiol. 2023 Sep 5:131342. doi: 10.1016/j.ijcard.2023.131342.
PubMed Abstract available

YAMAZAKI C, Higuchi R, Saji M, Takamisawa I, et al
Discrepancy between invasive and echocardiographic transvalvular gradient after TAVI: Insights from the LAPLACE-TAVI registry.
Int J Cardiol. 2023;386:17-23.
PubMed Abstract available

August 2023

GENTILE F, Buoncristiani F, Sciarrone P, Bazan L, et al
Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation.
Int J Cardiol. 2023 Aug 19:131272. doi: 10.1016/j.ijcard.2023.131272.
PubMed Abstract available

LI S, Fang L, Wu W, Zhang Z, et al
Echocardiographic diagnosis of rupture of mitral valve papillary muscle.
Int J Cardiol. 2023 Aug 18:131273. doi: 10.1016/j.ijcard.2023.131273.
PubMed Abstract available

PIERONI M, Ciabatti M, Bolognese L
Stroke in hypertrophic cardiomyopathy. Never mind the rhythm.
Int J Cardiol. 2023;385:41-42.
PubMed

NEMES A
The tricuspid annulus in repaired tetralogy of Fallot - what does it play and what does it not?
Int J Cardiol. 2023;385:22.
PubMed

July 2023

SISINNI A, Estevez-Loureiro R
The K-clip: Time for a new tricuspid valve focal annuloplasty system.
Int J Cardiol. 2023 Jul 31:131234. doi: 10.1016/j.ijcard.2023.131234.
PubMed

BARKI M, Ielasi A, Buono A, Maffeo D, et al
Transcatheter aortic valve replacement with the self-expanding ACURATE Neo2 in patients with horizontal aorta: Insights from the ITAL-neo registry.
Int J Cardiol. 2023 Jul 31:131236. doi: 10.1016/j.ijcard.2023.131236.
PubMed Abstract available

SANCHIS L, Farrero M
Edge to edge mitral valve repair beyond COAPT criteria: A bridge to further therapies for patients with advanced heart failure.
Int J Cardiol. 2023 Jul 31:131235. doi: 10.1016/j.ijcard.2023.131235.
PubMed

MIRZAI S, Aleixo GFP, Mazumder S, Berglund F, et al
Sarcopenia evaluation on cardiac magnetic resonance imaging in older adults for outcomes prediction following surgical aortic valve replacement.
Int J Cardiol. 2023 Jul 25:131216. doi: 10.1016/j.ijcard.2023.131216.
PubMed Abstract available

BHOGAL S, Rogers T, Merdler I, Reddy P, et al
Evolut PRO/PRO+ versus Evolut R system for transcatheter aortic valve replacement.
Int J Cardiol. 2023 Jul 19:131196. doi: 10.1016/j.ijcard.2023.131196.
PubMed Abstract available

ZHANG X, Jin Q, Pan W, Li W, et al
First-in-human study of the K-Clip transcatheter annular repair system for severe functional tricuspid regurgitation.
Int J Cardiol. 2023 Jul 11:131174. doi: 10.1016/j.ijcard.2023.131174.
PubMed Abstract available

CHATTERJEE A, Kazui T, Acharya D
Growing prevalence of aortic stenosis - Question of age or better recognition?
Int J Cardiol. 2023 Jul 8:131155. doi: 10.1016/j.ijcard.2023.131155.
PubMed

XU Z, Dai XF, Lin F, Chen LW, et al
Two-incision totally thoracoscopic mitral valve repair combined with radiofrequency atrial fibrillation ablation in rheumatic mitral valve disease: Early results of a case series of 43 consecutive patients.
Int J Cardiol. 2023 Jul 8:131158. doi: 10.1016/j.ijcard.2023.131158.
PubMed Abstract available

MASSERA D, Sherrid MV, Maron MS, Rowin EJ, et al
How common is hypertrophic cardiomyopathy... really?: Disease prevalence revisited 27 years after CARDIA.
Int J Cardiol. 2023;382:64-67.
PubMed Abstract available

SA MP, Tasoudis P, Jacquemyn X, Van den Eynde J, et al
Long-term outcomes of valve-sparing root versus composite valve graft replacement for acute type A aortic dissection: Meta-analysis of reconstructed time-to-event data.
Int J Cardiol. 2023;382:12-19.
PubMed Abstract available

June 2023

MARGONATO D, Ancona F, Cesari A, Ghantous E, et al
The long-term clinical course of moderate tricuspid regurgitation.
Int J Cardiol. 2023 Jun 24:131135. doi: 10.1016/j.ijcard.2023.131135.
PubMed Abstract available

LIND A, Esfahan MA, Totzeck M, Al-Rashid F, et al
Virtual reality-assisted distraction during transcatheter aortic valve implantation under local anaesthesia: A randomised study.
Int J Cardiol. 2023 Jun 22:131130. doi: 10.1016/j.ijcard.2023.131130.
PubMed Abstract available

MUNAFO AR, Scotti A, Estevez-Loureiro R, Adamo M, et al
2-year outcomes of MitraClip as a bridge to heart transplantation: The international MitraBridge registry.
Int J Cardiol. 2023 Jun 22:131139. doi: 10.1016/j.ijcard.2023.131139.
PubMed Abstract available

LEE M, Shechter A, Han D, Nguyen LC, et al
Left ventricular morphologic progression in apical hypertrophic cardiomyopathy.
Int J Cardiol. 2023;381:62-69.
PubMed Abstract available

BOURG C, Curtis E, Donal E
Navigating upstream and downstream: Unleashing the prognostic potential of RVFWLS/PASP ratio in severe tricuspid regurgitation.
Int J Cardiol. 2023 Jun 12:S0167-5273(23)00881.
PubMed

RAHIMI M, Kpodonu J
Myectomy or myomectomy, that is the question.
Int J Cardiol. 2023;380:28.
PubMed

SCHEFFERS LE, Kok R, van den Berg LE, van den Hout JMP, et al
Effects of enzyme replacement therapy on cardiac function in classic infantile Pompe disease.
Int J Cardiol. 2023;380:65-71.
PubMed Abstract available

May 2023

FERSTL P, Achenbach S, Marwan M, Bittner DO, et al
Comparison of oral anticoagulation by vitamin-K antagonists and non-vitamin-K antagonists for treatment of leaflet thickening after transcatheter aortic valve implantation (TAVI).
Int J Cardiol. 2023 May 25:S0167-5273(23)00727.
PubMed Abstract available

ZHOU Y, Lin X, Zhu Q, Li H, et al
Association between trajectories in cardiac damage and clinical outcomes after transcatheter aortic valve replacement.
Int J Cardiol. 2023 May 11:S0167-5273(23)00707.
PubMed Abstract available

FRANCESCO A, Davide M, Gregorio M, Matteo B, et al
Ratio between right ventricular longitudinal strain and pulmonary arterial systolic pressure: A novel prognostic parameter in patients with severe tricuspid regurgitation.
Int J Cardiol. 2023 May 4:S0167-5273(23)00647.
PubMed Abstract available

EGBE AC, Miranda WR, Anderson JH, Pellikka PA, et al
Left ventricular adaptation to aortic regurgitation in adults with repaired coarctation of aorta.
Int J Cardiol. 2023 May 4:S0167-5273(23)00650.
PubMed Abstract available

April 2023

AMBROSY AP, Go AS, Leong TK, Garcia EA, et al
Temporal trends in the prevalence and severity of aortic stenosis within a contemporary and diverse community-based cohort.
Int J Cardiol. 2023 Apr 27:S0167-5273(23)00601.
PubMed Abstract available

SHOJI S, Kuno T, Malik A, Briasoulis A, et al
Association between institutional volume of transcatheter mitral valve repair and readmission rates: A report from the National Readmission Database.
Int J Cardiol. 2023 Apr 19:S0167-5273(23)00588.
PubMed Abstract available

FUMAGALLI C, Bonanni F, Beltrami M, Ruggieri R, et al
Incidence of stroke in patients with hypertrophic cardiomyopathy in stable sinus rhythm during long-term monitoring.
Int J Cardiol. 2023 Apr 13:S0167-5273(23)00523.
PubMed Abstract available

LEIBOWITZ D, Yoshida Y, Jin Z, Nakanishi K, et al
Factors associated with the progression of aortic valve calcification in older adults.
Int J Cardiol. 2023 Apr 6:S0167-5273(23)00470.
PubMed Abstract available

ELKOUMY A, Jose J, Gunasekaran S, Kumar A, et al
Angiographic quantification of aortic regurgitation following myval octacor implantation; independent core lab adjudication.
Int J Cardiol. 2023 Apr 5:S0167-5273(23)00516.
PubMed Abstract available

MERLO M, Folgheraiter A, Sinagra G
Evolving mortality and clinical scenarios in HCM: Where are we?
Int J Cardiol. 2023;376:97-99.
PubMed

March 2023

MENG H, Zhao X, Wang JD, Wan LY, et al
Comparison between multimodality imaging approaches for measurement of the tricuspid annulus in severe tricuspid regurgitation.
Int J Cardiol. 2023 Mar 31:S0167-5273(23)00434.
PubMed Abstract available

DE MARZO V, Viglino U, Zecchino S, Matos JG, et al
Supra-renal aortic atheroma extent and composition predict acute kidney injury after transcatheter aortic valve replacement: A three-dimensional computed tomography study.
Int J Cardiol. 2023 Mar 29:S0167-5273(23)00464.
PubMed Abstract available

MENDEL B, Kohar K, Amirah S, Vidya AP, et al
The outcomes of fetal aortic valvuloplasty in critical aortic stenosis: A systematic review and meta-analysis.
Int J Cardiol. 2023 Mar 28:S0167-5273(23)00461.
PubMed Abstract available

SAMBOLA A, Soriano-Colome T
New insights into cardiovascular events in women after TAVI. Lessons from TAVI-WIN Registry.
Int J Cardiol. 2023;375:21-22.
PubMed

ESPOSITO G, Montalto C, Crimi G, Grippo R, et al
Time course of ischemic and bleeding burden in consecutive patients undergoing transcatheter aortic valve replacement (FOCUS-ONE registry).
Int J Cardiol. 2023 Mar 8:S0167-5273(23)00336.
PubMed Abstract available

ZAMPIERI M, Salvi S, Fumagalli C, Argiro A, et al
Clinical scenarios of hypertrophic cardiomyopathy-related mortality: Relevance of age and stage of disease at presentation.
Int J Cardiol. 2023;374:65-72.
PubMed Abstract available

February 2023

LEONE PP, Gohar A, Pagnesi M, Mangieri A, et al
Clinical outcomes in women and men with small aortic annuli undergoing transcatheter aortic valve implantation: A multicenter, retrospective, propensity score-matched comparison.
Int J Cardiol. 2023 Feb 28:S0167-5273(23)00270.
PubMed Abstract available

MALTES S, Abecasis J, Santos RR, Lopes P, et al
LGE prevalence and patterns in severe aortic stenosis: When "junctional" means the same.
Int J Cardiol. 2023 Feb 22:S0167-5273(23)00250.
PubMed Abstract available

GESKE JB, Siontis KC, Gersh BJ
Syncope in hypertrophic cardiomyopathy: Explaining the unexplained.
Int J Cardiol. 2023;373:99-100.
PubMed

D'ELIA N, Gall S, Potter E, Wright L, et al
Echocardiographic detection of heart valve disease in a community cohort of asymptomatic Australians > 65 years with cardiovascular risk factors.
Int J Cardiol. 2023;373:107-109.
PubMed Abstract available

ZHAO X, Jin F, Wang J, Zhao X, et al
Entropy of left ventricular late gadolinium enhancement and its prognostic value in hypertrophic cardiomyopathy a new CMR assessment method.
Int J Cardiol. 2023;373:134-141.
PubMed Abstract available

CONSTANTINE A, Dimopoulos K, Heng EL, Kempny A, et al
Transcatheter pulmonary valve implantation: An option for the few becoming an option for the many.
Int J Cardiol. 2023;373:44-46.
PubMed

YEERKEN M, Lu Y, Wang Q
The potency of transthoracic echocardiography in assessing arrhythmogenic trigger and substrate: Novel risk markers for malignant mitral valve prolapse.
Int J Cardiol. 2023 Feb 10:S0167-5273(23)00231.
PubMed

HAUM M, Humpfer F, Steffen J, Fischer J, et al
Quantification of physical activity with prospective activity tracking after transfemoral aortic valve replacement.
Int J Cardiol. 2023 Feb 7:S0167-5273(23)00168.
PubMed Abstract available

BREEMAN KTN, Peijster AJL, De Bruin-Bon HACM, Pepplinkhuizen S, et al
Worsening tricuspid regurgitation after ICD implantation is rather due to transvenous lead than natural progression.
Int J Cardiol. 2023 Feb 7:S0167-5273(23)00183.
PubMed Abstract available

January 2023

CRANE AD, Saijo Y, Kocyigit D, Tharwani A, et al
Severe mitral regurgitation in nonagenarians: Impact of symptomatic status, frailty and etiology on management and outcomes.
Int J Cardiol. 2023 Jan 23:S0167-5273(23)00066.
PubMed Abstract available

SRINIVASAN A, Brown J, Ahmed H, Daniel M, et al
PASCAL repair system for patients with mitral regurgitation: A systematic review.
Int J Cardiol. 2023 Jan 19:S0167-5273(23)00067.
PubMed Abstract available

LIN F, Wang Q, Meng L, Liang Y, et al
Cardiac computed tomography based analysis of mitral annulus, coronary sinus and left circumflex artery in patients with mitral regurgitation: Implications for transcatheter mitral annuloplasty techniques.
Int J Cardiol. 2023 Jan 18:S0167-5273(23)00064.
PubMed Abstract available

BHOGAL S, Waksman R, Gordon P, Ehsan A, et al
Subclinical leaflet thrombosis and antithrombotic therapy post-TAVI: An LRT substudy.
Int J Cardiol. 2023;371:305-311.
PubMed Abstract available

WANG K, Zhou M, Zhang Y, Du Y, et al
IRX2 activated by jumonji domain-containing protein 2A is crucial for cardiac hypertrophy and dysfunction in response to the hypertrophic stimuli.
Int J Cardiol. 2023;371:332-344.
PubMed Abstract available

THOMPSON SE, Prabhakar CRK, Creasey T, Stoll VM, et al
Pregnancy outcomes in women following the Ross procedure.
Int J Cardiol. 2023;371:135-139.
PubMed Abstract available

TOPRICEANU CC, Field E, Boleti O, Cervi E, et al
Disopyramide is a safe and effective treatment for children with obstructive hypertrophic cardiomyopathy.
Int J Cardiol. 2023;371:523-525.
PubMed Abstract available

PAGANO M, Fumagalli C, Girolami F, Passantino S, et al
Clinical profile and outcome of cardiomyopathies in infants and children seen at a tertiary centre.
Int J Cardiol. 2023;371:516-522.
PubMed Abstract available

STEFANO P, Argiro A, Bacchi B, Iannone L, et al
Does a standard myectomy exist for obstructive hypertrophic cardiomyopathy? From the Morrow variations to precision surgery.
Int J Cardiol. 2023;371:278-286.
PubMed Abstract available

DZIEWIERZ A
The time is always right to do what is right: TAVI and timing of PCI.
Int J Cardiol. 2023;371:128-129.
PubMed

YANG K, Yu SQ, Chen XY, Song YY, et al
Apical aneurysm formation in apical hypertrophic cardiomyopathy: Pilot study with cardiac magnetic resonance.
Int J Cardiol. 2023;371:480-485.
PubMed Abstract available

DE BRITO FS JR, Sarmento-Leite R, Dangas G
The ongoing dilemma of anticoagulation after TAVI: Seek quality evidence.
Int J Cardiol. 2023;371:329-330.
PubMed

MORAL S, Abuli M, Mendez I, Gonzalez-Gomez A, et al
Invasive management of significant tricuspid regurgitation in clinical practice.
Int J Cardiol. 2023 Jan 12:S0167-5273(23)00048.
PubMed Abstract available

FELDT K, Dalen M, Meduri CU, Kastengren M, et al
Reducing cardiac tamponade caused by temporary pacemaker perforation in transcatheter aortic valve replacement.
Int J Cardiol. 2023 Jan 11:S0167-5273(23)00047.
PubMed Abstract available

ESTEVEZ-LOUREIRO R, Barreiro-Perez M
Transcatheter tricuspid valve replacement: Beyond symptom improvement.
Int J Cardiol. 2023 Jan 5:S0167-5273(22)01978.
PubMed

KIM WK, Abdel-Wahab M
Higher short-term mortality of Evolut versus Sapien 3: A piece of the puzzle?
Int J Cardiol. 2023;370:351-352.
PubMed

BONAVENTURA J
Rediscovering therapies for hypertrophic cardiomyopathy.
Int J Cardiol. 2023;370:319-320.
PubMed

QIN L, Zhu S, Liu P, Zhu L, et al
Additional prognostic values of strain and strain rate over late gadolinium enhancement in hypertrophic cardiomyopathy patients.
Int J Cardiol. 2023;370:427-434.
PubMed Abstract available

BRIGNOLE M, Cecchi F, Anastasakis A, Crotti L, et al
Syncope in hypertrophic cardiomyopathy (part II): An expert consensus statement on the diagnosis and management.
Int J Cardiol. 2023;370:330-337.
PubMed Abstract available

BARBOSA MC, Cirillo W, Piza F, Figueiredo MJO, et al
Determinants and prognostic value of in-hospital infection in patients waiting for permanent pacemaker implantation.
Int J Cardiol. 2023;370:204-208.
PubMed Abstract available

HOUEIJEH A, Batteux C, Karsenty C, Ramdane N, et al
Long-term outcomes of transcatheter pulmonary valve implantation with melody and SAPIEN valves.
Int J Cardiol. 2023;370:156-166.
PubMed Abstract available

ARGIRO A, Zampieri M, Dei LL, Ferrantini C, et al
Safety and efficacy of ranolazine in hypertrophic cardiomyopathy: Real-world experience in a National Referral Center.
Int J Cardiol. 2023;370:271-278.
PubMed Abstract available

KIM EK, Hwang JW, Chang SA, Park SJ, et al
Different characteristics of apical aneurysm in hypertrophic cardiomyopathy are related to difference in long-term prognosis.
Int J Cardiol. 2023;370:287-293.
PubMed Abstract available

December 2022

STANKOVIC I, Dweck MR
Global strain in moderate aortic valve stenosis with reduced left ventricular ejection fraction: A piece of the puzzle.
Int J Cardiol. 2022 Dec 31:S0167-5273(22)01975.
PubMed

KO E, Park DW
Conduction disturbances after TAVR with newer-generation self-expanding valves.
Int J Cardiol. 2022;369:45-46.
PubMed

PELLICCIA A
New evidences recommend an active lifestyle in young HCM patients.
Int J Cardiol. 2022;369:82-83.
PubMed

YEERKEN M, Wen Y, Lv H, Tang B, et al
Arrhythmic mitral annular disjunction syndrome: An underestimated cause of sudden cardiac death.
Int J Cardiol. 2022;369:19-20.
PubMed

LERTSANGUANSINCHAI P, Chokesuwattanaskul R, Petchlorlian A, Suttirut P, et al
Machine learning-based predictive risk models for 30-day and 1-year mortality in severe aortic stenosis patients undergoing transcatheter aortic valve implantation.
Int J Cardiol. 2022 Dec 15:S0167-5273(22)01897.
PubMed Abstract available

DREYFUS J, Messika-Zeitoun D
Cardiac implantable electronic devices: Leads can lead to tricuspid regurgitation and death!
Int J Cardiol. 2022 Dec 7:S0167-5273(22)01884.
PubMed

LV H, Fan Y, Yeerken M, Gao L, et al
Radiofrequency ablation of hypertrophic obstructive cardiomyopathy - a potential method for clinical application.
Int J Cardiol. 2022;368:53-54.
PubMed

November 2022

VAN BERGEIJK KH, Wykrzykowska JJ, Sartori S, Snyder C, et al
Pre-procedural oral anticoagulant use is associated with cardiovascular events in women after transcatheter aortic valve replacement: An analysis from the WIN-TAVI cohort.
Int J Cardiol. 2022 Nov 28:S0167-5273(22)01743.
PubMed Abstract available

LEE H, Kim J, Jung JH, Yoo JS, et al
Surgical edge-to-edge repair for tricuspid regurgitation: Impact of the concomitant annuloplasty.
Int J Cardiol. 2022 Nov 28:S0167-5273(22)01742.
PubMed Abstract available

NING X, Cao J, Wang W, Xu Z, et al
Impact of transcatheter tricuspid valve replacement for tricuspid regurgitation on hepatic, cardiac, and venous structure.
Int J Cardiol. 2022 Nov 27:S0167-5273(22)01744.
PubMed Abstract available

OFFEN SM, Puranik R, Baker D, Cordina R, et al
Prevalence and determinants of tricuspid regurgitation after repair of tetralogy of Fallot.
Int J Cardiol. 2022 Nov 24:S0167-5273(22)01726.
PubMed Abstract available

STASSEN J, Singh GK, Pio SM, Chimed S, et al
Incremental value of left ventricular global longitudinal strain in moderate aortic stenosis and reduced left ventricular ejection fraction.
Int J Cardiol. 2022 Nov 22:S0167-5273(22)01722.
PubMed Abstract available

SA MP, Van den Eynde J, Simonato M, Hirji S, et al
Late outcomes of valve-in-valve transcatheter aortic valve implantation versus re-replacement: Meta-analysis of reconstructed time-to-event data.
Int J Cardiol. 2022 Nov 10. pii: S0167-5273(22)01699.
PubMed Abstract available

XU B, Khayata M
Isolated tricuspid valve surgery: The devil is infective endocarditis?
Int J Cardiol. 2022 Nov 2. pii: S0167-5273(22)01675.
PubMed

SALMASI MY, Morris-Rosendahl D, Jarral OA, Rosendahl U, et al
Determining the genetic contribution in patients with non-syndromic ascending thoracic aortic aneurysms: Correlation with findings from computational pathology.
Int J Cardiol. 2022;366:1-9.
PubMed Abstract available

FRANCIA P, Silvetti G, Cosentino P, Cristiano E, et al
Relation of delayed intrinsicoid deflection of the QRS complex to sudden cardiac death in patients with hypertrophic cardiomyopathy.
Int J Cardiol. 2022;366:42-47.
PubMed Abstract available

October 2022

OFFEN S, Strange G, Playford D, Celermajer DS, et al
Prevalence and prognostic impact of tricuspid regurgitation in patients with cardiac implantable electronic devices: From the national echocardiography database of Australia.
Int J Cardiol. 2022 Oct 29. pii: S0167-5273(22)01671.
PubMed Abstract available

STEFFEN J, Andreae D, Nabauer M, Reissig N, et al
TAVI for patients with normal-flow low-gradient compared to high-gradient aortic stenosis.
Int J Cardiol. 2022 Oct 25. pii: S0167-5273(22)01655.
PubMed Abstract available

PAN L, Deng Y, Dai S, Feng X, et al
Development and internal validation of a prediction model for acute kidney injury following cardiac valve replacement surgery.
Int J Cardiol. 2022 Oct 25. pii: S0167-5273(22)01657.
PubMed Abstract available

ALI LA, Marrone C, Martins DS, Khraiche D, et al
Prognostic factors in hypertrophic cardiomyopathy in children: An MRI based study.
Int J Cardiol. 2022;364:141-147.
PubMed Abstract available

ANDREASSEN K, Dejgaard LA, Lie O, Fink TS, et al
Exercise training during childhood and adolescence is associated with favorable diastolic function in hypertrophic cardiomyopathy.
Int J Cardiol. 2022;364:65-71.
PubMed Abstract available

SCOTTI A, Sturla M, Coisne A, Assafin M, et al
Monitoring conduction disturbances following TAVR: Feasibility study of early discharge using a novel telemetry patch.
Int J Cardiol. 2022;364:35-37.
PubMed Abstract available

MUSICANTE M, Kim HH, Chen Y, Liao F, et al
Regulation of endothelial nitric oxide synthase in cardiac remodeling.
Int J Cardiol. 2022;364:96-101.
PubMed Abstract available

September 2022

LERMAN TT, Levi A, Kornowski R
Meta-analysis of short- and long-term clinical outcomes of the self-expanding Evolut R/pro valve versus the balloon-expandable Sapien 3 valve for transcatheter aortic valve implantation.
Int J Cardiol. 2022 Sep 18. pii: S0167-5273(22)01385.
PubMed Abstract available

GESKE JB, Gersh BJ
Explaining unexplained syncope in hypertrophic cardiomyopathy: A clinical dilemma.
Int J Cardiol. 2022;363:125-126.
PubMed

HIGUCHI S, Orban M, Adamo M, Giannini C, et al
Sex-specific impact of anthropometric parameters on outcomes after transcatheter edge-to-edge repair for secondary mitral regurgitation.
Int J Cardiol. 2022 Sep 14. pii: S0167-5273(22)01337.
PubMed Abstract available

DI MAURO M, Russo M, Saitto G, Lio A, et al
Prognostic role of endocarditis in isolated tricuspid valve surgery. A propensity-weighted study.
Int J Cardiol. 2022 Sep 13. pii: S0167-5273(22)01330.
PubMed Abstract available

FANG M, Li B, Li X, Wang Y, et al
MicroRNA-29b regulates pyroptosis involving calcific aortic valve disease through the STAT3/SOCS1 pathway.
Int J Cardiol. 2022 Sep 2. pii: S0167-5273(22)01196.
PubMed Abstract available

LILLO R, Graziani F
Pregnancy in hypertrophic cardiomyopathy: New data, old questions.
Int J Cardiol. 2022;362:126-127.
PubMed

SHINTANI Y, Nakayama T, Masaki A, Yokoi M, et al
Clinical impact of the pathological quantification of myocardial fibrosis and infiltrating T lymphocytes using an endomyocardial biopsy in patients with hypertrophic cardiomyopathy.
Int J Cardiol. 2022;362:110-117.
PubMed Abstract available

OJEDA S, Pan M
Aortic annuli in transcatheter valve implantation: "The bigger is not the better".
Int J Cardiol. 2022;362:57-58.
PubMed

August 2022

NEDIOS S, Steven D, Sultan A
Atrioventricular coupling in hypertrophic cardiomyopathy: Partners in crime for new-onset atrial fibrillation.
Int J Cardiol. 2022 Aug 18. pii: S0167-5273(22)01195.
PubMed

AMAT-SANTOS IJ, Blasco-Turrion S, Avanzas P
Micro-dislodgement of Acurate neo 2 transcatheter heart valve: The right shoe for Cinderella.
Int J Cardiol. 2022;361:29-30.
PubMed

GALLO F, Gallone G, Kim WK, Reifart J, et al
Procedural outcomes of the 34 mm EvolutR Transcatheter valve in a real-world population insights from the HORSE multicenter collaborative registry.
Int J Cardiol. 2022;361:55-60.
PubMed Abstract available

FISCHLEIN T, Caporali E, Folliguet T, Kappert U, et al
Randomized controlled trial between conventional versus sutureless bioprostheses for aortic valve replacement: Impact of mini and full sternotomy access at 1-year follow-up.
Int J Cardiol. 2022 Aug 6. pii: S0167-5273(22)01179.
PubMed Abstract available

GRAZIANI F, Lillo R, Biagini E, Limongelli G, et al
Myocardial infarction with non-obstructive coronary arteries in hypertrophic cardiomyopathy vs Fabry disease.
Int J Cardiol. 2022 Aug 2. pii: S0167-5273(22)01116.
PubMed Abstract available

SAVVOULIDIS P, Mechery A, Lawton E, Ludman PF, et al
Comparison of left ventricular with right ventricular rapid pacing on tamponade during TAVI.
Int J Cardiol. 2022;360:46-52.
PubMed Abstract available

SICARI R
Diagnosing HCM severity: The role of microvascular impairment.
Int J Cardiol. 2022;360:44.
PubMed

July 2022

LUNARDI M, Venturi G, Del Sole PA, Ruzzarin A, et al
Optimal timing for percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation.
Int J Cardiol. 2022 Jul 21. pii: S0167-5273(22)01100.
PubMed Abstract available

AUNG H, Eleid MF
Thrombocytopenia as a marker of poor prognosis following transcatheter aortic valve implantation.
Int J Cardiol. 2022 Jul 18. pii: S0167-5273(22)01096.
PubMed

VELY M, L'official G, Galli E, Kosmala W, et al
Functional tricuspid regurgitation: A clustering analysis and prognostic validation of three echocardiographic phenotypes in an external cohort.
Int J Cardiol. 2022 Jul 16. pii: S0167-5273(22)01088.
PubMed Abstract available

MOOLLA M, Mathew A, John K, Yogasundaram H, et al
Outcomes of pregnancy in women with hypertrophic cardiomyopathy: A systematic review.
Int J Cardiol. 2022;359:54-60.
PubMed Abstract available

AGUIAR ROSA S, Lopes LR, Branco L, Galrinho A, et al
Blunted coronary flow velocity reserve is associated with impairment in systolic function and functional capacity in hypertrophic cardiomyopathy.
Int J Cardiol. 2022;359:61-68.
PubMed Abstract available

ALPERI A, Robichaud M, Panagides V, Mesnier J, et al
Impact of residual transvalvular gradient on clinical outcomes following valve-in-valve transcatheter aortic valve replacement.
Int J Cardiol. 2022 Jul 4. pii: S0167-5273(22)01024.
PubMed Abstract available

DILORENZO MP, DeCost G, Mai AD, Hughes N, et al
Comparison of serum biomarkers of myocardial fibrosis with cardiac magnetic resonance in patients operated for tetralogy of Fallot.
Int J Cardiol. 2022;358:27-33.
PubMed Abstract available

ALPERI A, Pascual I, Moris C, Avanzas P, et al
New-generation Ultra and PRO devices: Latest device iterations but old valve type effects.
Int J Cardiol. 2022;358:83-84.
PubMed

KIM WK, Renker M, Dorr O, Nef H, et al
Micro-dislodgement of a self-expanding transcatheter heart valve: Incidence, predictors, and outcomes.
Int J Cardiol. 2022;358:77-82.
PubMed Abstract available

June 2022

RHEUDE T, Pellegrini C, Allali A, Bleiziffer S, et al
Multicenter comparison of latest-generation balloon-expandable versus self-expanding transcatheter heart valves: Ultra versus Evolut.
Int J Cardiol. 2022;357:115-120.
PubMed Abstract available

MASCIA G, Crotti L, Groppelli A, Canepa M, et al
Syncope in hypertrophic cardiomyopathy (part I): An updated systematic review and meta-analysis.
Int J Cardiol. 2022;357:88-94.
PubMed Abstract available

KARDOS A, Rusinaru D, Marechaux S, Alskaf E, et al
Implementation of a CT-derived correction factor to refine the measurement of aortic valve area and stroke volume using Doppler echocardiography improves grading of severity and prediction of prognosis in patients with severe aortic stenosis.
Int J Cardiol. 2022 Jun 15. pii: S0167-5273(22)00917.
PubMed Abstract available

SOLLI CN, Chamat-Hedemand S, Elming H, Ngo A, et al
Coronary artery- and aortic valve calcifications in patients with Philadelphia-negative myeloproliferative neoplasms.
Int J Cardiol. 2022 Jun 15. pii: S0167-5273(22)00928.
PubMed Abstract available

MEUCCI MC, Fortuni F, Galloo X, Bootsma M, et al
Left atrioventricular coupling index in hypertrophic cardiomyopathy and risk of new-onset atrial fibrillation.
Int J Cardiol. 2022 Jun 15. pii: S0167-5273(22)00916.
PubMed Abstract available

LANDES U, Morelli O, Danenberg H, Sathananthan J, et al
Transcatheter aortic valve-in-valve implantation to treat aortic Para-valvular regurgitation after TAVI.
Int J Cardiol. 2022 Jun 11. pii: S0167-5273(22)00913.
PubMed Abstract available

May 2022

KE Y, Wang J, Wang W, Guo S, et al
Antithrombotic strategies after transcatheter aortic valve implantation: A systematic review and network meta-analysis of randomized controlled trials.
Int J Cardiol. 2022 May 30. pii: S0167-5273(22)00807.
PubMed Abstract available

CASTRO-MEJIA AF, Amat-Santos I, Ortega-Armas ME, Baz JA, et al
Development of atrioventricular and intraventricular conduction disturbances in patients undergoing transcatheter aortic valve replacement with new generation self-expanding valves: A real world multicenter analysis.
Int J Cardiol. 2022 May 9. pii: S0167-5273(22)00665.
PubMed Abstract available

MATSUSHITA K, Marchandot B, Kibler M, Heger J, et al
P2Y12 inhibition by clopidogrel increases adverse clinical events after transcatheter aortic valve replacement.
Int J Cardiol. 2022 May 4. pii: S0167-5273(22)00583.
PubMed Abstract available

MONDA E, Lioncino M, Palmiero G, Franco F, et al
Bisoprolol for treatment of symptomatic patients with obstructive hypertrophic cardiomyopathy. The BASIC (bisoprolol AS therapy in hypertrophic cardiomyopathy) study.
Int J Cardiol. 2022;354:22-28.
PubMed Abstract available

April 2022

SADEGHIPOUR P, Farrashi M, De Caterina R
Response to "non-vitamin K antagonist oral anticoagulants (NOACs) in preventing thromboembolism in atrial fibrillation patients with moderate to severe mitral stenosis: Results from a pilot trial".
Int J Cardiol. 2022 Apr 29. pii: S0167-5273(22)00637.
PubMed

CARBONE RG
Advancements in calcific aortic valve disease.
Int J Cardiol. 2022 Apr 22. pii: S0167-5273(22)00568.
PubMed

PANAGIDES V, Kalavrouziotis D, Dumont E, Delarochelliere R, et al
Carotid ultrasound following Transcarotid Transcatheter aortic valve replacement.
Int J Cardiol. 2022 Apr 22. pii: S0167-5273(22)00570.
PubMed Abstract available

YALCIN YC, Veenis JF, Brugts JJ, Antonides CFJ, et al
Rate of thromboembolic and bleeding events in patients undergoing concomitant aortic valve surgery with left ventricular assist device implantation.
Int J Cardiol. 2022 Apr 16. pii: S0167-5273(22)00555.
PubMed Abstract available

ZORZI A, Brunetti G, Corrado D
Differential diagnosis between athlete's heart and hypertrophic cardiomyopathy: New pieces of the puzzle.
Int J Cardiol. 2022;353:77-79.
PubMed

AUTORE C, Ferrazzi P
Patients with hypertrophic cardiomyopathy are getting older.
Int J Cardiol. 2022;353:73-74.
PubMed

BOUREAU AS, Karakachoff M, Le Scouarnec S, Capoulade R, et al
Heritability of aortic valve stenosis and bicuspid enrichment in families with aortic valve stenosis.
Int J Cardiol. 2022 Apr 12. pii: S0167-5273(22)00501.
PubMed Abstract available

KASTENGREN M, Settergren M, Ruck A, Feldt K, et al
Percutaneous plug-based vascular closure device in 1000 consecutive transfemoral transcatheter aortic valve implantations.
Int J Cardiol. 2022 Apr 12. pii: S0167-5273(22)00513.
PubMed Abstract available

JOLOBE OMP
Characteristics of the prothrombotic milieu in mitral stenosis patients managed with direct oral anticoagulants.
Int J Cardiol. 2022 Apr 10. pii: S0167-5273(22)00509.
PubMed

LI L, Dai M, Fu Y
Non-vitamin K antagonist oral anticoagulants (NOACs) in preventing thromboembolism in atrial fibrillation patients with moderate to severe mitral stenosis: Results from a pilot trial.
Int J Cardiol. 2022 Apr 10. pii: S0167-5273(22)00508.
PubMed

PANAGIDES V, Mohammadi S, Rodes-Cabau J
Cranial nerve injury: A word of caution for transcarotid transcatheter aortic valve replacement.
Int J Cardiol. 2022 Apr 7. pii: S0167-5273(22)00497.
PubMed

WEGENER A, Holm AE, Gomes LC, Lima KO, et al
Prevalence of rheumatic heart disease in adults from the Brazilian Amazon Basin.
Int J Cardiol. 2022;352:115-122.
PubMed Abstract available

March 2022

GOEL A, Malik AH, Gupta R, Rawal H, et al
Concomitant tricuspid valve repair in patients undergoing mitral valve surgery: A recent update.
Int J Cardiol. 2022 Mar 16. pii: S0167-5273(22)00388.
PubMed

SADEGHIPOUR P, Pouraliakbar H, Parsaee M, Shojaeifard M, et al
RIvaroxaban in mitral stenosis (RISE MS): A pilot randomized clinical trial.
Int J Cardiol. 2022 Mar 16. pii: S0167-5273(22)00396.
PubMed Abstract available

MENNINI FS, Meucci F, Pesarini G, Vandoni P, et al
Cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in low surgical risk aortic stenosis patients.
Int J Cardiol. 2022 Mar 16. pii: S0167-5273(22)00393.
PubMed Abstract available

MCGRATH D, Zhan Y
Cranial nerve injury: A word of caution for transcarotid transcatheter aortic valve replacement.
Int J Cardiol. 2022 Mar 16. pii: S0167-5273(22)00390.
PubMed

SANTOS-MARTINEZ S, Halim J, Castro-Mejia A, De Marco F, et al
Myval versus alternative balloon- and self-expandable transcatheter heart valves: A central core lab analysis of conduction disturbances.
Int J Cardiol. 2022;351:25-31.
PubMed Abstract available

ARGIRO A, Rosenblum H, Griffin J, Batra J, et al
Sex related differences in exercise performance in patients with hypertrophic cardiomyopathy: Hemodynamic insights through non-invasive pressure volume analysis.
Int J Cardiol. 2022;351:78-83.
PubMed Abstract available

TARASOUTCHI F, Rosa VEE
Rivaroxaban effects on cardiac valve calcifications, renal preservation and inflammatory modulation: Have we found the panacea?
Int J Cardiol. 2022;351:89-90.
PubMed

ALBUQUERQUE AM, Brophy JM
Pacemaker risk following transcatheter aortic valve replacement - A Bayesian reanalysis.
Int J Cardiol. 2022 Mar 11. pii: S0167-5273(22)00328.
PubMed Abstract available

RENKER M, Kim WK
Assessment of frailty prior to TAVI: Can it now be measured objectively?
Int J Cardiol. 2022;350:104-105.
PubMed

WERNER N, Renker M, Dorr O, Bauer T, et al
Anatomical suitability and off-label use of contemporary transcatheter heart valves.
Int J Cardiol. 2022;350:96-103.
PubMed Abstract available

February 2022

LIMONGELLI G, Monda E
Implantable cardioverter defibrillator in hypertrophic cardiomyopathy: Time to avoid unnecessary procedure.
Int J Cardiol. 2022 Feb 22. pii: S0167-5273(22)00265.
PubMed

CHARITOS E, Kim WK
Conduction disturbances following transcatheter aortic valve implantation: Any room for improvement?
Int J Cardiol. 2022 Feb 16. pii: S0167-5273(22)00252.
PubMed

MASSERA D, Xia Y, Li B, Riedy K, et al
Mitral annular calcification in hypertrophic cardiomyopathy.
Int J Cardiol. 2022;349:83-89.
PubMed Abstract available

TABATA N, Tsujita K
Disparities in transcatheter mitral valve repair - Disparities being corrected little by little?
Int J Cardiol. 2022 Feb 14. pii: S0167-5273(22)00245.
PubMed

SALA A, Lorusso R, Alfieri O
Isolated tricuspid regurgitation: A plea for early correction.
Int J Cardiol. 2022 Feb 4. pii: S0167-5273(22)00195.
PubMed Abstract available

TIRADO-CONTE G, Salazar CH, McInerney A, Cruz-Utrilla A, et al
Incidence, clinical impact and predictors of thrombocytopenia after transcatheter aortic valve replacement.
Int J Cardiol. 2022 Feb 3. pii: S0167-5273(22)00198.
PubMed Abstract available

January 2022

PANAGIDES V, Kalavrouziotis D, Dumont E, Delarochelliere R, et al
Cranial nerve injury during transcarotid transcatheter aortic valve replacement.
Int J Cardiol. 2022 Jan 31. pii: S0167-5273(22)00187.
PubMed Abstract available

YA'QOUB L, Alkhouli M, Elgendy IY
Symptomatic improvement using the New York Heart Association classification as a predictor for survival after transcatheter edge-to-edge repair of the mitral valve.
Int J Cardiol. 2022 Jan 23. pii: S0167-5273(22)00132.
PubMed

REDDAVID C, Costa G, Valvo R, Criscione E, et al
Transcatheter aortic valve implantation during COVID-19 pandemic: An optimized model to relieve healthcare system overload.
Int J Cardiol. 2022 Jan 22. pii: S0167-5273(22)00128.
PubMed Abstract available

ZHANG C, Liu M, Wang X, Chen S, et al
Mechanism of CircANKRD36 regulating cell heterogeneity and endothelial mesenchymal transition in aortic valve stromal cells by regulating miR-599 and TGF-beta signaling pathway.
Int J Cardiol. 2022 Jan 21. pii: S0167-5273(22)00134.
PubMed Abstract available

LECLERCQ F, Lorca L, Agullo A, Bouchdoug K, et al
Evolution of right ventricular dysfunction and tricuspid regurgitation after TAVI: A prospective study.
Int J Cardiol. 2022 Jan 20. pii: S0167-5273(22)00123.
PubMed Abstract available

HASSOUN R, Budde H, Zhazykbayeva S, Herwig M, et al
Do they come together? Protein quality control, stress-activated signaling, and "sarcostat" in hypertrophic cardiomyopathy progression.
Int J Cardiol. 2022;347:44-45.
PubMed

FUMAGALLI C, De Filippo V, Zocchi C, Tassetti L, et al
Strength of clinical indication and therapeutic impact of the implantable cardioverter defibrillator in patients with hypertrophic cardiomyopathy.
Int J Cardiol. 2022 Jan 11. pii: S0167-5273(22)00069.
PubMed Abstract available

December 2021

ALPERI A, Pascual I, Moris C, Avanzas P, et al
Valve type selection for bicuspid aortic valves in TAVR: Does the key lie in the annular size?
Int J Cardiol. 2021 Dec 31. pii: S0167-5273(21)02049.
PubMed

SUDO M, Sugiura A, Treiling L, Al-Kassou B, et al
Baseline PA/BSA ratio in patients undergoing transcatheter aortic valve replacement - A novel CT-based marker for the prediction of pulmonary hypertension and outcome.
Int J Cardiol. 2021 Dec 16. pii: S0167-5273(21)02011.
PubMed Abstract available

NEGRI F, Muser D, Driussi M, Sanna GD, et al
Prognostic role of global longitudinal strain by feature tracking in patients with hypertrophic cardiomyopathy: The STRAIN-HCM study.
Int J Cardiol. 2021;345:61-67.
PubMed Abstract available

MASCIA G, Olivotto I, Brugada J, Arbelo E, et al
Sport practice in hypertrophic cardiomyopathy: running to stand still?
Int J Cardiol. 2021;345:77-82.
PubMed Abstract available

ALPERI A, Pascual I, Avanzas P, Moris C, et al
Atrial-FMR: No longer the forgotten mechanism of functional mitral regurgitation.
Int J Cardiol. 2021 Dec 14. pii: S0167-5273(21)01999.
PubMed

HEIDARI B, Ahmad A, Al-Hijji MA, Aoun J, et al
Muscle fat index is associated with frailty and length of hospital stay following transcatheter aortic valve replacement in high-risk octogenarians.
Int J Cardiol. 2021 Dec 3. pii: S0167-5273(21)01978.
PubMed Abstract available

HASSOUN R, Budde H, Zhazykbayeva S, Herwig M, et al
Stress activated signalling impaired protein quality control pathways in human hypertrophic cardiomyopathy.
Int J Cardiol. 2021;344:160-169.
PubMed Abstract available

November 2021

BENFARI G, Cavalcante JL, Enriquez-Sarano M
Multimodality imaging in functional mitral regurgitation: Valvular disease and the chamber remodeling quantification.
Int J Cardiol. 2021 Nov 30. pii: S0167-5273(21)01955.
PubMed

MOSCARELLA E, Mangieri A, Giannini F, Tchetche D, et al
Annular size and interaction with trans-catheter aortic valves for treatment of severe bicuspid aortic valve stenosis: Insights from the BEAT registry.
Int J Cardiol. 2021 Nov 26. pii: S0167-5273(21)01871.
PubMed Abstract available

RUBBIO AP, Testa L, Grasso C, Sisinni A, et al
Transcatheter edge-to-edge mitral valve repair in atrial functional mitral regurgitation insights from the multi-center MITRA-TUNE registry.
Int J Cardiol. 2021 Nov 23. pii: S0167-5273(21)01844.
PubMed Abstract available

WENZL FA, Ambrosini S, Paneni F
Molecular underpinnings of myocardial stiffness in patients with hypertrophic cardiomyopathy.
Int J Cardiol. 2021;343:80-82.
PubMed

KHAN U, Shaw T, Kempny A, Gatzoulis MA, et al
The clinical presentation and outcome of aortic coarctation associated with left ventricular inflow and outflow tract lesion in adult patients: Shone syndrome and beyond.
Int J Cardiol. 2021;343:45-49.
PubMed Abstract available

PFEIFER P, Zietzer A, Holscher M, Jehle J, et al
Transverse aortic constriction-induced heart failure leads to increased levels of circulating microparticles.
Int J Cardiol. 2021 Nov 10. pii: S0167-5273(21)01772.
PubMed Abstract available

GIORDANO A, Biondi-Zoccai G, Finizio F, Ferraro P, et al
Characteristics and outcomes of MitraClip in octogenarians: Evidence from 1853 patients in the GIOTTO registry.
Int J Cardiol. 2021;342:65-71.
PubMed Abstract available

October 2021

HASIN T, Mann D, Welt M, Barrett O, et al
Loss of left ventricular rotation is a significant determinant of functional mitral regurgitation.
Int J Cardiol. 2021 Oct 6. pii: S0167-5273(21)01509.
PubMed Abstract available

AL-MOHAMMAD A
The impact of cMR on echocardiographic markers of severe aortic regurgitation, a story of synergy.
Int J Cardiol. 2021 Oct 5. pii: S0167-5273(21)01503.
PubMed

BENITO-GONZALEZ T, Carrasco-Chinchilla F, Estevez-Loureiro R, Pascual I, et al
Clinical and echocardiographic outcomes of transcatheter mitral valve repair in atrial functional mitral regurgitation.
Int J Cardiol. 2021 Oct 2. pii: S0167-5273(21)01497.
PubMed Abstract available

SIONTIS KC, Liu K, Bos JM, Attia ZI, et al
Detection of hypertrophic cardiomyopathy by an artificial intelligence electrocardiogram in children and adolescents.
Int J Cardiol. 2021;340:42-47.
PubMed Abstract available

September 2021

FUJITA H, Toba T, Miwa K, Suzuki M, et al
The impact of computed tomography-derived aortic atheroma volume on prognosis after transcatheter aortic valve replacement.
Int J Cardiol. 2021 Sep 30. pii: S0167-5273(21)01494.
PubMed Abstract available

GEYER M, Keller K, Tamm AR, Born S, et al
Early symptomatic benefit indicates long-term prognosis after transcatheter mitral valve edge-to-edge repair in functional and degenerative etiology.
Int J Cardiol. 2021 Sep 23. pii: S0167-5273(21)01479.
PubMed Abstract available

MONDA E, Palmiero G, Lioncino M, Rubino M, et al
External validation of the increased wall thickness score for the diagnosis of cardiac amyloidosis.
Int J Cardiol. 2021;339:99-101.
PubMed Abstract available

PAPANASTASIOU CA, Zegkos T, Kokkinidis DG, Parcharidou D, et al
Prognostic role of left ventricular apical aneurysm in hypertrophic cardiomyopathy: A systematic review and meta-analysis.
Int J Cardiol. 2021;339:108.
PubMed

EL KHOUDARY SR, Fabio A, Yester JW, Steinhauser ML, et al
Design and rationale of a clinical trial to increase cardiomyocyte division in infants with tetralogy of Fallot.
Int J Cardiol. 2021;339:36-42.
PubMed Abstract available

RODRIGUES T, Raposo SC, Brito D, Lopes LR, et al
Prognostic relevance of exercise testing in hypertrophic cardiomyopathy. A systematic review.
Int J Cardiol. 2021;339:83-92.
PubMed Abstract available

YA'QOUB L, Jneid H, Elgendy IY
Transcatheter edge-to-edge repair of the mitral valve: A promising bridge to heart transplant for select patients?
Int J Cardiol. 2021 Sep 9. pii: S0167-5273(21)01330.
PubMed

XU YP, Zhang P
Letter on "Prognostic role of left ventricular apical aneurysm in hypertrophic cardiomyopathy: A systematic review and meta-analysis".
Int J Cardiol. 2021;338:152.
PubMed

NAMDAR M, Richardot P, Johner N, Shah D, et al
Recognition of pre-hypertrophic cardiac involvement in Fabry Disease based on automated electrocardiographic measures.
Int J Cardiol. 2021;338:121-126.
PubMed Abstract available

KAWASHIMA H, Serruys PW, Mylotte D, Rosseel L, et al
Operator preference and determinants of size selection when additional intermediate-size aortic transcatheter heart valves are made available.
Int J Cardiol. 2021;338:168-173.
PubMed Abstract available

FABI M, Calicchia M, Palleri D, Ndikubwimana I, et al
Pediatric rheumatic carditis in Italy and Rwanda: The same disease, different socio-economic settings.
Int J Cardiol. 2021;338:154-160.
PubMed Abstract available

BABAPOOR-FARROKHRAN S, Pressman GS
Mitral annular disjunction: A myocardial abnormality too?
Int J Cardiol. 2021;338:174-175.
PubMed

August 2021

GAO SA, Polte CL, Lagerstrand KM, Bech-Hanssen O, et al
The usefulness of left ventricular volume and aortic diastolic flow reversal for grading chronic aortic regurgitation severity - Using cardiovascular magnetic resonance as reference.
Int J Cardiol. 2021 Aug 30. pii: S0167-5273(21)01311.
PubMed Abstract available

QIN L, Chen C, Gu S, Zhou M, et al
A radiomic approach to predict myocardial fibrosis on coronary CT angiography in hypertrophic cardiomyopathy.
Int J Cardiol. 2021;337:113-118.
PubMed Abstract available

July 2021

WONG I, Sondergaard L, De Backer O
Computational simulation models to test bioprosthetic aortic valves: A valuable alternative or addition to bench testing?
Int J Cardiol. 2021 Jul 30. pii: S0167-5273(21)01200.
PubMed

CATERINAA M, Andreaa R, Pompiliob F
Aortic valve stenosis burden: Where we are now?
Int J Cardiol. 2021 Jul 19. pii: S0167-5273(21)01177.
PubMed

ROBERTS-THOMSON RL, Baumann AAW, Reade J, Culgan L, et al
Surgical and percutaneous management of Aboriginal Australians with rheumatic heart disease: Timeliness and concordance between practice and guidelines.
Int J Cardiol. 2021;335:80-84.
PubMed Abstract available

HINOJAR R, Gomez AG, Garcia-Martin A, Monteagudo JM, et al
Impact of right ventricular systolic function in patients with significant tricuspid regurgitation. A cardiac magnetic resonance study.
Int J Cardiol. 2021 Jul 14. pii: S0167-5273(21)01168.
PubMed Abstract available

KAMPAKTSIS PN, Tzoumas A
LV apical aneurysm in HCM: Implant ICD and anticoagulate?: Editorial comment on: "Prognostic role of left ventricular apical aneurysm in hypertrophic cardiomyopathy: A systematic review and meta-analysis."
Int J Cardiol. 2021;334:86-87.
PubMed

WANG TKM, Kwon DH, Abou-Hassan O, Chetrit M, et al
Strain evaluation for mitral annular disjunction by echocardiography and magnetic resonance imaging: A case-control study.
Int J Cardiol. 2021;334:154-156.
PubMed Abstract available

June 2021

DOLDI PM, Buech J, Orban M, Samson-Himmelstjerna P, et al
Transcatheter mitral valve repair may increase eligibility for heart transplant listing in patients with end-stage heart failure and severe secondary mitral regurgitation.
Int J Cardiol. 2021 Jun 19. pii: S0167-5273(21)01029.
PubMed Abstract available

PELLICCIA F, Pasceri V
The less-is-better effect: The case of alcohol dose in septal ablation for hypertrophic cardiomyopathy.
Int J Cardiol. 2021;333:143-144.
PubMed

MARTIN M, Junco-Vicente A, Rodriguez I
Bicuspid aortopathy in adolescents: Another piece of the puzzle.
Int J Cardiol. 2021;333:94-95.
PubMed

NARANG R, Saxena A, Ramakrishnan S, Gupta SK, et al
An evidence-based scoring system to diagnose acute rheumatic fever with carditis in children.
Int J Cardiol. 2021;333:146-151.
PubMed Abstract available

RODRIGUEZ-GABELLA T, Zimarino M, Barbanti M, Testa L, et al
Sex based analysis of the impact of red blood cell transfusion and vascular or bleeding complications related to TAVI - The TRITAVI-Women Study.
Int J Cardiol. 2021;333:69-76.
PubMed Abstract available

VESELKA J, Faber L, Liebregts M, Cooper R, et al
Alcohol dose in septal ablation for hypertrophic obstructive cardiomyopathy.
Int J Cardiol. 2021;333:127-132.
PubMed Abstract available

MOSCARELLI M, Gallo F, Gallone G, Kim WK, et al
Aortic angle distribution and predictors of horizontal aorta in patients undergoing transcatheter aortic valve replacement.
Int J Cardiol. 2021 Jun 6. pii: S0167-5273(21)00911.
PubMed Abstract available

UY J, Ketkar AG, Portnoy A, Kim JJ, et al
Cost-utility analysis of heart surgeries for young adults with severe rheumatic mitral valve disease in India.
Int J Cardiol. 2021 Jun 4. pii: S0167-5273(21)00916.
PubMed Abstract available

PAPANASTASIOU CA, Zegkos T, Karamitsos TD, Rowin EJ, et al
Prognostic role of left ventricular apical aneurysm in hypertrophic cardiomyopathy: A systematic review and meta-analysis.
Int J Cardiol. 2021;332:127-132.
PubMed Abstract available

MAGRI D, Gallo G
Cardiopulmonary exercise testing: An increasingly important step in managing hypertrophic cardiomyopathy.
Int J Cardiol. 2021;332:138-139.
PubMed

SARRAJ-ASIL A, Diez-Villanueva P
Insight into functional tricuspid valve regurgitation pathogenesis, pathological stages, and surgical management.
Int J Cardiol. 2021 Jun 1. pii: S0167-5273(21)00903.
PubMed Abstract available

May 2021

VON KAPPELGAARD L, Gislason G, Davidsen M, Zwisler AD, et al
Temporal trends and socioeconomic differences in treatment and mortality following a diagnosis of aortic stenosis.
Int J Cardiol. 2021 May 27. pii: S0167-5273(21)00896.
PubMed Abstract available

WANG Z, Zhao L, He S
Prognostic nutritional index and the risk of mortality in patients with hypertrophic cardiomyopathy.
Int J Cardiol. 2021;331:152-157.
PubMed Abstract available

SEGGEWISS H, Batzner A
Surgical myectomy in HOCM: Still gold standard for septal reduction?
Int J Cardiol. 2021;331:174-175.
PubMed

TOME ESTEBAN MT
Gender disease-dose in hypertrophic cardiomyopathy.
Int J Cardiol. 2021;331:172-173.
PubMed

D'ASCENZO F, Bruno F, Baldetti L, De Filippo O, et al
Aortic valve replacement vs. balloon-expandable and self-expandable transcatheter implantation: A network meta-analysis.
Int J Cardiol. 2021 May 8. pii: S0167-5273(21)00811.
PubMed Abstract available

OOMS JF, Ceusters J, Hirsch A, Budde RPJ, et al
Accuracy of three-dimensional computational modeling in prediction of the dynamic neo left ventricular outflow tract with transcatheter mitral valve replacement.
Int J Cardiol. 2021 May 6. pii: S0167-5273(21)00814.
PubMed Abstract available

VILADES D, Garcia-Moll X, Gomez-Llorente M, Pujadas S, et al
Differentiation of athlete's heart and hypertrophic cardiomyopathy by the fractal dimension of left ventricular trabeculae.
Int J Cardiol. 2021;330:232-237.
PubMed Abstract available

MUKAI K
Cardiac magnetic resonance T1 mapping: A novel quality assurance program paving the way towards standardization and wider clinical practice.
Int J Cardiol. 2021;330:266-267.
PubMed

YAMAMURA K, Duarte V, Karur GR, Graf J, et al
The impact of pulmonary valve replacement on pregnancy outcomes in women with tetralogy of Fallot.
Int J Cardiol. 2021;330:43-49.
PubMed Abstract available

ZHANG Q, Werys K, Popescu IA, Biasiolli L, et al
Quality assurance of quantitative cardiac T1-mapping in multicenter clinical trials - A T1 phantom program from the hypertrophic cardiomyopathy registry (HCMR) study.
Int J Cardiol. 2021;330:251-258.
PubMed Abstract available

XU F, Chen Y, Tillman KA, Cui Y, et al
Characterizing modifier genes of cardiac fibrosis phenotype in hypertrophic cardiomyopathy.
Int J Cardiol. 2021;330:135-141.
PubMed Abstract available

April 2021

TRIMAILLE A, Hmadeh S, Matsushita K, Schini-Kerth V, et al
Reply to "Patients with aortic stenosis exhibit early improved endothelial function following transcatheter aortic valve replacement: The eFAST study" by Comella et al.
Int J Cardiol. 2021 Apr 29. pii: S0167-5273(21)00747.
PubMed

LI C, Tang D, Yao J, Shao Y, et al
Porcine and bovine aortic valve comparison for surgical optimization: A fluid-structure interaction modeling study.
Int J Cardiol. 2021 Apr 28. pii: S0167-5273(21)00740.
PubMed Abstract available

DEKANY G, Fontos G, Satish S, Szabo G, et al
The prognostic value of immediate post-TAVI hemodynamic evaluation is superior to aortography and transoesophageal echocardiography in predicting patient survival.
Int J Cardiol. 2021;329:153-161.
PubMed Abstract available

MIDTBO H, Hauge SW, Haaverstad R, Dalen H, et al
How reproducible is the diagnosis of borderline rheumatic heart disease?
Int J Cardiol. 2021;328:163-164.
PubMed

BATZNER A, Aicha D, Pfeiffer B, Neugebauer A, et al
Sex-related differences in symptomatic patients with hypertrophic obstructive cardiomyopathy - Time for a new definition?
Int J Cardiol. 2021;328:117-121.
PubMed Abstract available

PRADEGAN N, Leon-Wyss JR, Iribarren JR, Garcia E, et al
Contemporary trends in surgical rheumatic valve disease in a Caribbean nation.
Int J Cardiol. 2021;328:215-217.
PubMed Abstract available

KHARBANDA RK, Lodder L, Ragab AAY, de Jong PL, et al
Early and late post-operative arrhythmias after surgical myectomy: 45 years of follow-up.
Int J Cardiol. 2021;328:63-68.
PubMed Abstract available

March 2021

GIANNINI C, Angelillis M, Fiorina C, Tamburino C, et al
Clinical impact and evolution of mitral regurgitation after TAVI using the new generation self-expandable valves.
Int J Cardiol. 2021 Mar 31. pii: S0167-5273(21)00630.
PubMed Abstract available

DE MARZO V, Dettori S, Nicolini LA, Vercellino M, et al
Early infections after successful transcatheter aortic valve replacement are associated with increased short- and long-term mortality: A single-center study.
Int J Cardiol. 2021 Mar 27. pii: S0167-5273(21)00622.
PubMed Abstract available

OH JK, Lee SH, Lee SA, Kang DY, et al
Prognostic impact of left ventricular mass regression after transcatheter aortic valve replacement in patients with left ventricular hypertrophy.
Int J Cardiol. 2021 Mar 26. pii: S0167-5273(21)00557.
PubMed Abstract available

KIM WK, Doerr O, Renker M, Choi YH, et al
Initial experience with a novel, modular, minimalistic approach for transfemoral aortic valve implantation.
Int J Cardiol. 2021 Mar 26. pii: S0167-5273(21)00564.
PubMed Abstract available

COMELLA A, Michail M, Chan J, Cameron JD, et al
Patients with aortic stenosis exhibit early improved endothelial function following transcatheter aortic valve replacement: The eFAST study.
Int J Cardiol. 2021 Mar 26. pii: S0167-5273(21)00566.
PubMed Abstract available

LLOYD JW, Eleid MF
Simplifying the approach to classical low-flow low-gradient severe aortic stenosis: A renewed emphasis on the resting transthoracic echocardiogram.
Int J Cardiol. 2021 Mar 22. pii: S0167-5273(21)00547.
PubMed

SIURANA JM, Sabate-Rotes A, Ayerza A, Jimenez L, et al
Adolescents with bicuspid aortic valve: Which criteria should we use for aortic dilatation?
Int J Cardiol. 2021 Mar 20. pii: S0167-5273(21)00545.
PubMed Abstract available

JOSEPH N, Craft M, Mill L, Erickson CC, et al
Assessment of mitral valve function in children and young adults with hypertrophic cardiomyopathy using three-dimensional echocardiography.
Int J Cardiol. 2021 Mar 19. pii: S0167-5273(21)00544.
PubMed Abstract available

AMAT-SANTOS IJ, Barrero A
New conduction abnormalities following aortic valve-in-valve: The weakest link of a strong chain.
Int J Cardiol. 2021 Mar 18. pii: S0167-5273(21)00478.
PubMed

MANCONE M, Infusino F, Fedele F, Sardella G, et al
Transcervical approach for TAVI: Perhaps more than a fallback.
Int J Cardiol. 2021;327:66-67.
PubMed

SCOLARI FL, Faganello LS, Garbin HI, Piva E Mattos B, et al
A systematic review of microRNAs in patients with hypertrophic cardiomyopathy.
Int J Cardiol. 2021;327:146-154.
PubMed Abstract available

KOCHAV SM, Raita Y, Fifer MA, Takayama H, et al
Predicting the development of adverse cardiac events in patients with hypertrophic cardiomyopathy using machine learning.
Int J Cardiol. 2021;327:117-124.
PubMed Abstract available

BERNARD J, Tastet L, Capoulade R, Shen M, et al
Left ventricular asymmetric remodeling and subclinical left ventricular dysfunction in patients with calcific aortic valve stenosis - Results from a subanalysis of the PROGRESSA study.
Int J Cardiol. 2021 Mar 13. pii: S0167-5273(21)00474.
PubMed Abstract available

HOKKEN TW, van Wiechen MP, Ooms JF, El Azzouzi I, et al
Impact of Interventricular membranous septum length on pacemaker need with different Transcatheter aortic valve implantation systems.
Int J Cardiol. 2021 Mar 3. pii: S0167-5273(21)00391.
PubMed Abstract available

KELLERMAIR J, Saeed S, Chambers JB, Kammler J, et al
Predictors of true-severe classical low-flow low-gradient aortic stenosis at resting echocardiography.
Int J Cardiol. 2021 Mar 1. pii: S0167-5273(21)00381.
PubMed Abstract available

February 2021

XIE MY, Hou LJ
LncRNA MALAT1 aggravates calcific aortic valve disease by sponging miR-195.
Int J Cardiol. 2021 Feb 26. pii: S0167-5273(21)00370.
PubMed

KRALER S, Wenzl FA, Akhmedov A, Blaser MC, et al
ApoA-I mimetics improve aortic stenosis-associated left-ventricular diastolic dysfunction but fail to benefit rabbit models with normal aortic valves.
Int J Cardiol. 2021 Feb 21. pii: S0167-5273(21)00297.
PubMed

AKODAD M, Aldhaheri E, Marin G, Roubille F, et al
Transcatheter aortic valve replacement performed with selective telemetry monitoring: A prospective study.
Int J Cardiol. 2021 Feb 20. pii: S0167-5273(21)00281.
PubMed Abstract available

TENGLER A, Ulrich S, Fischer M, Pastor-Villaescusa B, et al
Rationale and feasibility of transcatheter pulmonary valve implantation in small conduits with the Edwards Sapien valves.
Int J Cardiol. 2021;325:45-50.
PubMed Abstract available

STANKOWSKI T, Mangner N, Linke A, Aboul-Hassan SS, et al
Cardiac conduction abnormalities in patients with degenerated bioprostheses undergoing transcatheter aortic valve-in-valve implantations and their impact on long-term outcomes.
Int J Cardiol. 2021 Feb 13. pii: S0167-5273(21)00282.
PubMed Abstract available

FIDOCK B, Archer G, Barker N, Elhawaz A, et al
Standard and emerging CMR methods for mitral regurgitation quantification.
Int J Cardiol. 2021 Feb 3. pii: S0167-5273(21)00148.
PubMed Abstract available

January 2021

WANG H, Song H, Yang Y, Wu Z, et al
Morphology display and hemodynamic testing using 3D printing may aid in the prediction of LVOT obstruction after mitral valve replacement.
Int J Cardiol. 2021 Jan 31. pii: S0167-5273(21)00110.
PubMed Abstract available

LUQUE T, Noriega FJ, McInerney A, Travieso A, et al
Impact of delirium in acute cardiac care unit after transcatheter aortic valve replacement.
Int J Cardiol. 2021 Jan 30. pii: S0167-5273(21)00135.
PubMed Abstract available

REIFART J, Liebetrau C, Weferling M, Dorr O, et al
Single versus double use of a suture-based closure device for transfemoral aortic valve implantation.
Int J Cardiol. 2021 Jan 30. pii: S0167-5273(21)00125.
PubMed Abstract available

ANDO T, Onishi T, Tobaru T
Extremely severe aortic stenosis - Is TAVR the answer?
Int J Cardiol. 2021 Jan 28. pii: S0167-5273(21)00085.
PubMed

VALLABHAJOSYULA S, Vallabhajosyula S, Yang LT, Rabinstein AA, et al
Frequency of intracranial aneurysms and sub-arachnoid hemorrhage is significantly lesser in bicuspid aortic valve than aortic coarctation.
Int J Cardiol. 2021 Jan 28. pii: S0167-5273(21)00127.
PubMed Abstract available

KOFFLARD MJM
Pacing in hypertrophic obstructive cardiomyopathy: First choice therapy in low volume centers?
Int J Cardiol. 2021;323:199-200.
PubMed

DORSCH LM, Kuster DWD, Jongbloed JDH, Boven LG, et al
The effect of tropomyosin variants on cardiomyocyte function and structure that underlie different clinical cardiomyopathy phenotypes.
Int J Cardiol. 2021;323:251-258.
PubMed Abstract available

HUURMAN R, Schinkel AFL, de Jong PL, van Slegtenhorst MA, et al
Impact of sex on timing and clinical outcome of septal myectomy for obstructive hypertrophic cardiomyopathy.
Int J Cardiol. 2021;323:133-139.
PubMed Abstract available

KONECNY T, Khoo M, Covassin N, Edelhofer P, et al
Increased heart rate with sleep disordered breathing in hypertrophic cardiomyopathy.
Int J Cardiol. 2021;323:155-160.
PubMed Abstract available

NACHAR W, Merlet N, Maafi F, Mihalache-Avram T, et al
ApoA-I mimetic does not improve left ventricular diastolic dysfunction in rabbits without aortic valve stenosis.
Int J Cardiol. 2021 Jan 6. pii: S0167-5273(20)34337.
PubMed Abstract available

SAJI M, Higuchi R, Izumi Y, Takamisawa I, et al
Transcatheter aortic valve replacement in patients with extremely severe aortic stenosis.
Int J Cardiol. 2021 Jan 5. pii: S0167-5273(20)34328.
PubMed Abstract available

MICELI A, Di Bacco L, Donatelli F, Glauber M, et al
Can we solve two problems with a TAVR?
Int J Cardiol. 2021;322:95-96.
PubMed

JAVIDGONBADI D, Andersson B, Abdon NJ, Ostman-Smith I, et al
Morbidity and resource usage after myectomy- or pacing-treatment in hypertrophic obstructive cardiomyopathy: A case-control study.
Int J Cardiol. 2021;322:197-203.
PubMed Abstract available

RYU AJ, Kumar V, Borlaug BA, Manduca A, et al
Systolic-to-diastolic myocardial volume ratio as a novel imaging marker of cardiomyopathy.
Int J Cardiol. 2021;322:272-277.
PubMed Abstract available

December 2020

IACOVELLI F, Pignatelli A, Cafaro A, Stabile E, et al
Impact of contrast medium osmolality on the risk of acute kidney injury after transcatheter aortic valve implantation: Insights from the magna Graecia TAVI registry.
Int J Cardiol. 2020 Dec 23. pii: S0167-5273(20)34297.
PubMed Abstract available

KHERALLAH RY, Harrison D, Preventza O, Silva GV, et al
Transcatheter aortic valve replacement after chest radiation: A propensity-matched analysis.
Int J Cardiol. 2020 Dec 22. pii: S0167-5273(20)34302.
PubMed Abstract available

USUKU H, Yamamoto E, Noguchi M, Komorita T, et al
Elevated C-reactive protein is significantly associated with left ventricular dysfunction in patients with aortic regurgitation and concomitant collagen disease.
Int J Cardiol. 2020 Dec 22. pii: S0167-5273(20)34301.
PubMed Abstract available

ALI FM, Ong G, Edwards J, Connelly KA, et al
Comparison of transcatheter tricuspid valve repair using the MitraClip NTR and XTR systems.
Int J Cardiol. 2020 Dec 7. pii: S0167-5273(20)34244.
PubMed Abstract available

TRIPATHI B, Sawant AC, Sharma P, Tandon V, et al
Short term outcomes after transcatheter mitral valve repair.
Int J Cardiol. 2020 Dec 2. pii: S0167-5273(20)34219.
PubMed Abstract available

November 2020

PASCANER AF, Houriez-Gombaud-Saintonge S, Craiem D, Gencer U, et al
Comprehensive assessment of local and regional aortic stiffness in patients with tricuspid or bicuspid aortic valve aortopathy using magnetic resonance imaging.
Int J Cardiol. 2020 Nov 28. pii: S0167-5273(20)34169.
PubMed Abstract available

LU H, Monney P, Fournier S, Pavon AG, et al
Transcervical approach versus transfemoral approach for transcatheter aortic valve replacement.
Int J Cardiol. 2020 Nov 23. pii: S0167-5273(20)34149.
PubMed Abstract available

CHENG YY, Chow V, Brieger D, Yan TD, et al
Outcomes of 16,436 patients requiring isolated aortic valve surgery: A statewide cohort study.
Int J Cardiol. 2020 Nov 9. pii: S0167-5273(20)34084.
PubMed Abstract available

MONDA E, Limongelli G
The hospitalizations in hypertrophic cardiomyopathy: "The dark side of the moon".
Int J Cardiol. 2020;318:101-102.
PubMed

MAOR E, Barbash IM
TAVR review of reviews: A new view on the horizon.
Int J Cardiol. 2020;318:43-44.
PubMed

October 2020

IELASI A, Moscarella E, Mangieri A, Giannini F, et al
Procedural and clinical outcomes of type 0 versus type 1 bicuspid aortic valve stenosis undergoing trans-catheter valve replacement with new generation devices: Insight from the BEAT international collaborative registry.
Int J Cardiol. 2020 Oct 22. pii: S0167-5273(20)34003.
PubMed Abstract available

ANDO T, Adegbala O, Aggarwal A, Afonso L, et al
Redo aortic valve intervention after transcatheter aortic valve replacement: Analysis of the nationwide readmission database.
Int J Cardiol. 2020 Oct 22. pii: S0167-5273(20)33991.
PubMed Abstract available

ZHANG Y, Fan P, Zhang H, Ma W, et al
Clinical characteristics and outcomes of chronic heart failure in adult Takayasu arteritis: A cohort study of 163 patients.
Int J Cardiol. 2020 Oct 18. pii: S0167-5273(20)33984.
PubMed Abstract available

LESSICK J
Is CMR the gold standard for evaluating transvalvular flow?
Int J Cardiol. 2020;317:221-222.
PubMed

JENSEN JK, Poulsen SH
Left atrial systolic function by strain analysis - A new useful prognostic tool in primary severe mitral regurgitation?
Int J Cardiol. 2020 Oct 6. pii: S0167-5273(20)33911.
PubMed

YILDIRIM OT, Ozgeyik M, Ozgeyik MO
Safety of transcatheter aortic valve replacement at malignancy patients.
Int J Cardiol. 2020 Oct 4. pii: S0167-5273(20)33907.
PubMed

June 2020

MATHEW J, Nguyen A, Nishimura RA, Geske JB, et al
Septal Myectomy in patients with previous coronary revascularization - hypertrophic cardiomyopathy masquerading as ischemic heart disease.
Int J Cardiol. 2020 Jun 19. pii: S0167-5273(20)33393.
PubMed Abstract available

April 2020

CHEN Y, O'Mahony C
The price and value of implantable cardioverter defibrillators in hypertrophic cardiomyopathy.
Int J Cardiol. 2020 Apr 2. pii: S0167-5273(20)30939.
PubMed

February 2020

MAGNUSSON P, Wimo A
Health economic evaluation of implantable cardioverter defibrillators in hypertrophic cardiomyopathy in adults.
Int J Cardiol. 2020 Feb 20. pii: S0167-5273(19)35600.
PubMed Abstract available

KALBACHER D, Daubmann A, Tigges E, Hunlich M, et al
Impact f pre- and post-procedural renal dysfunction on long-term outcomes in patients undergoing MitraClip implantation: A retrospective analysis from two German high-volume centres.
Int J Cardiol. 2020;300:87-92.
PubMed

MAURIZI N, Rella V, Fumagalli C, Salerno S, et al
Prevalence of cardiac amyloidosis among adult patients referred to tertiary centres with an initial diagnosis of hypertrophic cardiomyopathy.
Int J Cardiol. 2020;300:191-195.
PubMed Abstract available

January 2020

YANG H, Bouma BJ, Dimopoulos K, Khairy P, et al
Non-vitamin K antagonist oral anticoagulants (NOACs) for thromboembolic prevention, are they safe in congenital heart disease? Results of a worldwide study.
Int J Cardiol. 2020;299:123-130.
PubMed Abstract available

LIMONGELLI G, Monda E, Tramonte S, Gragnano F, et al
Prevalence and clinical significance of red flags in patients with hypertrophic cardiomyopathy.
Int J Cardiol. 2020;299:186-191.
PubMed Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Valvular Heart Disease is free of charge.